No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - Elementis shot higher on Tuesday after saying it will return around $35m of net cash proceeds to shareholders following completion of the sale of its pharmaceutical manufacturing business.
The company revealed in March that it was selling the business to Primark owner Associated British Foods for 34m.
On Tuesday, it announced the return of around $35m to shareholders by way of a share buyback "in recognition of Elementis's robust balance sheet, strong first quarter performance and unchanged outlook for the year".
It said the buyback would begin as soon as practicable.
Chief executive Luc van Ravenstein said: "We are pleased to have completed the sale of the pharmaceutical manufacturing business. The transaction further strengthens the quality of our portfolio and sharpens our focus on our core markets. We are excited about the opportunities ahead and the positive momentum behind our Elevate Elementis strategy."
At 0905 BST, the shares were up 6.1% at 161p.
See latest RNS on Investegate
The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.